CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 169 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $75,897,000 | -17.5% | 2,700 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $91,962,000 | -11.9% | 2,700 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $104,328,000 | -28.4% | 2,700 | 0.0% | 0.02% | -30.4% |
| Q3 2021 | $145,773,000 | +61.5% | 2,700 | 0.0% | 0.02% | +53.3% |
| Q2 2021 | $90,288,000 | +46.1% | 2,700 | -10.0% | 0.02% | +25.0% |
| Q1 2021 | $61,800,000 | +17.6% | 3,000 | 0.0% | 0.01% | +9.1% |
| Q4 2020 | $52,560,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,132,259 | $30,526,000 | 7.80% |
| Ghost Tree Capital, LLC | 400,000 | $10,784,000 | 5.62% |
| Octagon Capital Advisors LP | 761,398 | $20,527,000 | 5.48% |
| VR Adviser, LLC | 865,116 | $23,324,000 | 4.59% |
| ACUTA CAPITAL PARTNERS, LLC | 267,195 | $7,204,000 | 4.01% |
| COMMODORE CAPITAL LP | 538,812 | $14,526,000 | 3.07% |
| Ikarian Capital, LLC | 616,700 | $16,628,000 | 3.03% |
| TSP Capital Management Group, LLC | 266,545 | $7,186,000 | 2.83% |
| Ikarian Capital, LLC | 537,958 | $14,504,000 | 2.64% |
| Ikarian Capital, LLC | 506,500 | $13,656,000 | 2.49% |